Welcome to Nutraceuticals World   
July/August 2014 Issue
Last Updated Tuesday, July 29 2014
Print

Decas Botanical Synergies



Published January 6, 2010
Decas Botanical Synergies, Carver, MA, has obtained approval from the Korean Food and Drug Administration (KFDA) for use of a health claim supporting urinary health on its PACran, proanthocyanidin (PAC) standardized cranberry powder. The approval process for PACran took nearly two years to complete and was obtained after the company and its Korean partner, Monature, submitted a complete clinical dossier that included required safety data.


Receive free Nutraceuticals World emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Nutraceuticals World On